These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 182167)

  • 1. The catalytic effect of the carcinogen "4-nitroquinoline-N-oxide" on the oxidation of vitamin C.
    Biaglow JE; Jacobson B; Koch C
    Biochem Biophys Res Commun; 1976 Jun; 70(4):1316-23. PubMed ID: 182167
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemistry of 4-nitroquinoline 1-oxide and related compounds.
    Kawazoe Y
    Carcinog Compr Surv; 1981; 6():1-24. PubMed ID: 6786742
    [No Abstract]   [Full Text] [Related]  

  • 3. Formation of a cyclic adenine adduct with a 4-nitroquinoline N-oxide metabolite model.
    Tohme N; Demeunynck M; Lhomme MF; Lhomme J
    IARC Sci Publ; 1986; (70):241-5. PubMed ID: 3098679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 4-nitroquinoline 1-oxide and related compounds.
    Tada M
    Carcinog Compr Surv; 1981; 6():25-45. PubMed ID: 6786744
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Chemical structure of QAII, one of the covalently bound adducts of carcinogenic 4-nitroquinoline 1-oxide with nucleic acid bases of cellular nucleic acids.
    Kawazoe Y; Araki M; Huang F; Okamoto T; Tada M
    Chem Pharm Bull (Tokyo); 1975 Nov; 23(11):3041-3. PubMed ID: 815010
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic reduction of 4-nitroquinoline N-oxide and other radical-producing drugs to oxygen-reactive intermediates.
    Biaglow JE; Jacobson BE; Nygaard OF
    Cancer Res; 1977 Sep; 37(9):3306-13. PubMed ID: 406989
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of molybdenum on reduction of 4-nitroquinoline 1-oxide (author's transl)].
    Morita I; Iigo M; Fukino H; Sakai K; Yamane Y
    Yakugaku Zasshi; 1975 Aug; 95(8):954-8. PubMed ID: 810569
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomimetic preparation and structure determination of QGI, one of the quinoline-DNA base adducts formed in cells treated with 4-nitroquinoline 1-oxide.
    Tada M; Kohda KH; Kawazoe Y
    Gan; 1984 Nov; 75(11):976-85. PubMed ID: 6097493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of human cytomegalovirus by the chemical carcinogen 4-nitroquinoline 1-oxide.
    Albrecht T; Speelman DJ; Li JL
    J Gen Virol; 1979 Oct; 45(1):231-6. PubMed ID: 230304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on ascorbic acid. I. Factors influencing the ascorbate-mediated inhibition of catalase.
    Orr CW
    Biochemistry; 1967 Oct; 6(10):2995-3000. PubMed ID: 4964357
    [No Abstract]   [Full Text] [Related]  

  • 11. Main binding sites of the carcinogen, 4-nitroquinoline 1-oxide in nucleic acids.
    Tada M; Tada M
    Biochim Biophys Acta; 1976 Dec; 454(3):558-66. PubMed ID: 826278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenicity of 4-nitrosoquinoline 1-oxide and its possible role in carcinogenesis by 4-nitroquinoline 1-oxide.
    Takahashi K; Kawazoe Y; Tada M; Tada M; Ito N; Okada M
    Gan; 1978 Aug; 69(4):499-505. PubMed ID: 101415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells.
    Varnes ME; Biaglow JE
    Cancer Res; 1979 Aug; 39(8):2960-5. PubMed ID: 110443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine inhibition of the metabolic activation of a carcinogen, 4-nitroquinoline-1-oxide, in cultured Chinese hamster cells.
    Tsuda H; Yoshida D; Mizusaki S
    Carcinogenesis; 1984 Mar; 5(3):331-4. PubMed ID: 6200248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhancement of reduction activity of 4-nitroquinoline N-oxide in rats pretreated with 3-methylcholanthrene-type PCB].
    Yoshimura H; Koga N; Wada I; Hokama Y; Kuroki J
    Fukuoka Igaku Zasshi; 1983 May; 74(5):217-21. PubMed ID: 6411563
    [No Abstract]   [Full Text] [Related]  

  • 16. Formation of 8-hydroxyguanine residues in cellular DNA exposed to the carcinogen 4-nitroquinoline 1-oxide.
    Kohda K; Tada M; Kasai H; Nishimura S; Kawazoe Y
    Biochem Biophys Res Commun; 1986 Sep; 139(2):626-32. PubMed ID: 3094520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium binding of carcinogens and antitumor antibiotics to DNA: site selectivity, cooperativity, allosterism.
    Winkle SA; Krugh TR
    Nucleic Acids Res; 1981 Jul; 9(13):3175-86. PubMed ID: 6456451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of 4-nitroquinoline 1-oxide to 4-hydroxyaminoquinoline 1-oxide in lysates of cytomegalovirus-infected cells.
    Speelman DJ; Lund H; Culling A; Kittredge JS; Williams BJ; Albrecht T
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2511-5. PubMed ID: 6315869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excision in vitro of the DNA bound carcinogen, 4-nitroquinoline 1-oxide.
    Yoshida S; Tada M; Tada M
    Nucleic Acids Res; 1976 Nov; 3(11):3227-33. PubMed ID: 188019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncovalent binding of 4-nitroquinoline-N-oxide to proteins.
    Yamamoto O
    J Radiat Res; 1979 Dec; 20(4):276-83. PubMed ID: 119853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.